top of page

Introduction of Shingrix® for immunocompromised individuals for whom Zostavax® is clinically contrai

From 1 September 2021, GPs will offer the non-live shingles vaccine Shingrix® to all those who are eligible for shingles vaccination but are clinically contraindicated to receive the live vaccine Zostavax® due to their immunocompromised status. This is based on the recommendation made by the Joint Committee on Vaccination and Immunisation (JCVI). 2 In line with the current requirements of the shingles programme, the vaccine will be offered via a proactive call to those becoming eligible at 70 years old and will be offered opportunistically or if requested for those over 70 years until the age of 80.

14 views0 comments

Comments


bottom of page